Clinical Trial Update: A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer

View source ↗

Summary

A completed clinical trial evaluates a radiomic model to predict local recurrence risk and disease-free survival in patients with T3-T4 non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jinling Hospital, China | Conditions: Lung Cancer, Nonsmall Cell | Status: COMPLETED